中国中药控股有限公司于2026年3月2日发布了截至2026年2月28日的股份变动月报表。公告显示，公司普通股上月底及本月底结存均为5,035,801,852股，期间未发生任何新增发行、购回、注销或库藏股变动，已发行股份总数保持稳定。
报告指出，公司无股份期权及股权激励计划变动，也无可换股票据、认股权证或其他衍生工具的发行与注销记录。公司同时确认，截至本月末满足香港联交所关于上市公司最低公众持股量的规定。
公司在公告中表示，已严格遵守香港联交所《上市规则》及相关法律法规。该份月报由公司秘书伍秀薇签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.